Ropivacaine in epidural anaesthesia is known to cause less motor blockade and high maternal satisfaction.
INTRODUCTION
Pain during childbirth is one of the most excruciating pain experienced by women in their lives. 1 Fear of childbirth has been associated with a longer first and second stage of labour and dissatisfaction with the childbirth experience. 2 Most women who deliver in modern obstetric units request for some form of pharmacological or non-pharmacological pain relief. The ideal obstetric analgesic used should be cheap, easy to administer, produce good and reliable relief from pain but not impair consciousness and cooperation. It should have minimal maternal and neonatal adverse. A variety of labour analgesia options are available, including psychoprophylaxis, transcutaneous electrical nerve stimulation (TENS), systemic medication, inhalational techniques, and neuraxial blocks. In addition, other regional techniques such as caudal or para-cervical block are used infrequently.
Epidural analgesia effectively relieves labour pain and is now chosen by many parturient women. In addition to their analgesic benefits, the physiological benefits of epidural analgesia for the mother and fetus are welldocumented. [3] [4] [5] [6] Whether epidural analgesia affects labour and delivery is a matter of debate.
Tramadol is a weak opioid which inhibits nor-adrenergic and serotonergic transmission, having analogous analgesic efficacy to other opioids like meperidine but is without much maternal sedation and neonatal respiratory depression. It can be used by various routes such as oral, intramuscular, intravenous and epidural with minimal side effects. It is a potent analgesic which can be given to the labouring patients. Parenteral tramadol is being a less invasive alternative. It can be given by obstetricians themselves.
This study aims to compare the two widely used obstetrical analgesia techniques, parenteral tramadol and epidural ropivacaine with regard to their analgesic effect and maternal and labour outcome.
METHODS
This prospective, comparative, interventional clinical study was conducted at Kasturba hospital, Daryaganj, Delhi, on the patients admitted in labour room of the hospital during the period of September 2014 to July 2015.
All primigravida patients planned for vaginal delivery and in spontaneous active labour with full term singleton pregnancy in vertex presentation were included. Patients with medical disorders like hypertension, diabetes, renal disorder, heart disease, anemia, multiple pregnancy, malpresentations, previous cesarean and history of allergy to ananesthetic/analgesic agents were excluded. After selecting patients using the above criteria, an informed consent was taken. Complete history and examination of the patient was done. Weight and height of all the patients was measured and patients with weight between 50 to 80 kg and height 140 to 170 cm only were included. All routine antenatal investigations were done. Two groups were made with 50 patients in each group. Patients in group A received 100 mg tramadol intramuscularly in the upper outer quadrant of the buttocks at the onset of active labour. Same dose was repeated after 6 hours, if required. In Group B, 50 patients received lumbar epidural block and were administered 12 to 20 ml of 0.2% ropivacaine (depending upon patient's height) for initial injection through epidural catheter and 6ml of the same concentration was given for top up as and when required.
Following parameters of maternal condition and labour outcome in each group were monitored and compared:-
Degree of pain relief and patient satisfaction
Quality of analgesia using a visual analogue scale (VAS) score from 0-10 with 0 denoting no pain, and 10 indicating worst pain imaginable by the parturient. The VAS score was taken prior to induction/injection and then 1, 5, 10, 20, 30, 60 minutes and hourly thereafter, after placement of the block/injecting tramadol, and maximum analgesia was noted.
Effects on labour and delivery including
Duration of 1 st and 2 nd stage of labour. P/V and dilation of cervix at the time of administering analgesia and duration of labour from administration of analgesia to full dilatation of cervix and interval from full dilatation of cervix to delivery of the baby was noted.
Mode of delivery
Normal/instrumental/cesarean section.
Effect on the 3rd stage of labour
Active management of third stage was done for all the patients by administering 10 units oxytocin I/M within 1 minute of delivery. Duration of third stage and any third stage complication, like PPH and retained placenta were noted and any intervention required including MRP and measures used to control PPH were noted.
Side effects
Including nausea, vomiting, giddiness, dizziness and any untoward reaction was noted. The data was analyzed using appropriate statistical tests (chi square test, fisher's test, unpaired t-test). Mean age of patients in tramadol group was 23.14±4.06 and mean age in epidural group was 22.92±4.21. Difference between age groups and gestational ages was statistically not significant (Table 1) .
RESULTS
Patients less than 4 cm were not included in the study. Initial cervical dilation in both the groups was comparable ( Table 2 ). All patients included in the study had unbearable pain before analgesia and most of them rated it as worst pain they've ever had. All patients labelled the VAS score between 8 to10 before any analgesia was administered.
After receiving 100mg I/M tramadol, only 34% patients had a significant fall in VAS scores (VAS ±5). Maximum fall in VAS score was to 2 (2 patients). In 30% of patients, VAS score remained between 8 to 10 after receiving 100 mg I/M tramadol. Mean VAS score in tramadol group after analgesia was 6.3. There was no significant fall in VAS score after tramadol (p =0.186). In the epidural ropivacaine group, 92% patients had a significant fall in VAS score i.e less than or equal to 5. 28% patients had VAS score 0 to 1. In 4% of patients VAS score was 8-10 after giving analgesia.
Mean VAS score after epidural ropivacaine was 3.18. Significant fall in VAS score was observed after the use of epidural ropivacaine (p=0.000). There was significant difference between mean VAS after analgesia between the two groups and significantly better analgesic efficacy was observed with epidural ropivacaine compared to I/M tramadol (Table 3) . (Table 6 ). (Table 7) . Difference between the mean duration of 2 nd stage between the two groups was statistically not significant ( Table 8 ).
All the patients in tramadol group and 44 patients (97.78%) in epidural group had delivery of placenta within 20 minutes. Only one patient in the epidural group had retained placenta when MRP was done. Mean duration of 3rd stage in tramadol group was 8.38±6.52 min and in epidural group was 8.89±8.78min. Difference between the mean in two groups was statistically not significant (Table 9 ). Third stage was actively managed in all patients by administering 10 units oxytocin I/M within 1 min of delivery. In both the groups, two patients each had atonic PPH which was controlled by uterine massage, 20units oxytocin drip and injection metherg in 0.2 mg I/M In epidural group, one patient had retained placenta, for which manual removal of placenta was done. There was no significant difference in the complications observed in 3 rd stage in between the two groups (Table 10 ). showed no such side effect. Two patients in epidural group had giddiness whereas no such effect was seen with tramadol. The difference was statistically not significant (Table 11 ).
DISCUSSION
Ninety percent of patients in both groups were in 21 to 25 years age group. Mean age of patients in tramadol group was 23.14±4.06 and in epidural group was 22.92±4.21. The difference between age distribution and gestational ages of the two was statistically not significant which was similar to that seen in a randomized trial of epidural analgesia conducted by Sharma et al. 7 In the comparative study on epidural analgesia in labour (using lidocaine and fentanyl) versus no analgesia by Mousa et al, median of initial cervical dilation for all the patients was 4 cm which was similar to that seen in our study. 8 11, 12 In tramadol group, 4 patients underwent LSCS due to fetal distress. In epidural group, 5 patients underwent LSCS due to fetal distress and 1 patient had forceps delivery due to poor maternal bearing down efforts. The results of our study were similar to that by Mousa et al where no increase in rate of instrumental deliveries and cesarean section was seen in epidural group compared to the tramadol group.
But the results of our study differ from that of Sharma et al which showed higher instrumental delivery rates with epidural compared to I/V meperidine because of use of bupivacaine instead of ropivacaine during epidural analgesia as bupivacaine has more effect on the motor nerves as compared to ropivacaine.
Patients undergoing vaginal delivery were compared for duration of the first and second stage of labour. The difference between the two groups was statistically not significant. The finding of our study is concordant to that found by Loughnan et al and Mousa et al. 8, 10 However it differs from the conclusions of Sharma et al probably due to use of bupivacaine. 7 Six percent patients in tramadol group were found to have nausea and vomiting whereas epidural ropivacaine showed no such side effect. Our results differed from that of Mousa et al in that no hypotension was observed in the epidural group in the present study. 10 However two patients had transient giddiness. The results of tramadol group were similar to that conducted by Viegas et al, in that the side effects of tramadol were not significant. 13 
